drugset / Trial / NCT03876002
Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET
NaSingle-groupOpen-labelOther
Summary
The overall goal of this protocol is to evaluate microglial activation in the brain using \[18F\]PBR06 in patients with amyotrophic lateral sclerosis (ALS).
Timeline
- Start
- 2016-06-28
- Primary completion
- 2018-02-07
- Completion
- 2018-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [F-18]PBR06 | Diagnostic / imaging agent | 203.5 mbq | Intravenous |